ENRIGHT VINCENT D 4
4 · Echo Therapeutics, Inc. · Filed Jul 3, 2012
Insider Transaction Report
Form 4
ENRIGHT VINCENT D
Director
Transactions
- Award
Common Stock
2012-06-30+6,250→ 195,834 total
Footnotes (1)
- [F1]The shares vest on June 30, 2013, provided, however, that all unvested shares immediately vest upon the sale of all or substantially all of the assets of the Company or all or substantially all of the outstanding capital stock of the Company in exchange for Liquid Proceeds. "Liquid Proceeds" means (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold upon on NYSE or NASDAQ upon termination of a lock-up period not to exceed one hundred eighty (180) days; or (d) or a combination of cash and the foregoing securities.